ID: ALA4875677

Max Phase: Preclinical

Molecular Formula: C22H23FN6O

Molecular Weight: 406.47

Molecule Type: Unknown

Associated Items:

Representations

Canonical SMILES:  CCc1cc(Nc2nc(NCCc3ccc(F)cc3)nc3ccc(OC)cc23)n[nH]1

Standard InChI:  InChI=1S/C22H23FN6O/c1-3-16-12-20(29-28-16)26-21-18-13-17(30-2)8-9-19(18)25-22(27-21)24-11-10-14-4-6-15(23)7-5-14/h4-9,12-13H,3,10-11H2,1-2H3,(H3,24,25,26,27,28,29)

Standard InChI Key:  RWMMOVBRAQNAFV-UHFFFAOYSA-N

Associated Targets(Human)

G protein-coupled receptor kinase 6 1545 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 406.47Molecular Weight (Monoisotopic): 406.1917AlogP: 4.46#Rotatable Bonds: 8
Polar Surface Area: 87.75Molecular Species: NEUTRALHBA: 6HBD: 3
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 3#RO5 Violations (Lipinski): 0
CX Acidic pKa: 13.20CX Basic pKa: 5.54CX LogP: 5.23CX LogD: 5.22
Aromatic Rings: 4Heavy Atoms: 30QED Weighted: 0.40Np Likeness Score: -1.31

References

1. Uehling DE, Joseph B, Chung KC, Zhang AX, Ler S, Prakesch MA, Poda G, Grouleff J, Aman A, Kiyota T, Leung-Hagesteijn C, Konda JD, Marcellus R, Griffin C, Subramaniam R, Abibi A, Strathdee CA, Isaac MB, Al-Awar R, Tiedemann RE..  (2021)  Design, Synthesis, and Characterization of 4-Aminoquinazolines as Potent Inhibitors of the G Protein-Coupled Receptor Kinase 6 (GRK6) for the Treatment of Multiple Myeloma.,  64  (15.0): [PMID:34291633] [10.1021/acs.jmedchem.1c00506]

Source